Macimorelin
A synthetic growth hormone secretagogue used as a diagnostic agent to test for adult growth hormone deficiency by stimulating the release of growth hormone from the pituitary gland. It is taken orally before a blood test to measure the body's growth hormone response.
Peso Molecular
474,6000 g/mol
LogP
1,80
TPSA
145,00 Ų
Regra dos 5 de Lipinski
Aprovado
Mecanismo de Ação
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Estrutura 2D
Cite this structure
Embed this structure
SMILES
CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc1c[nH]c2ccccc12)NC=O
InChI
InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1
Molecular Formula
C26H30N6O3
HBD / HBA
6 / 4
Ligações Rotacionáveis
9
Átomos Pesados
35
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
A synthetic growth hormone secretagogue used as a diagnostic agent to test for adult growth hormone deficiency by stimulating the release of growth hormone from the pituitary gland. It is taken orally before a blood test to measure the body's growth hormone response.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Macimorelin is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL278623. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 9804938. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="macimorelin"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/macimorelin/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/macimorelin/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/macimorelin/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="macimorelin"></drugfyi-drug>